VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO 2017 | Innovative approaches to the treatment of head and neck cancer

Jean-Pascal Machiels • 8 Sep 2017
ESMO 2017
Warning: array_filter() expects parameter 1 to be array, bool given in /home/customer/www/vjoncology.com/public_html/wp-content/themes/vj/single.php on line 281

Jean-Pascal Machiels, MD, PhD, from the Cliniques Universitaires Saint-Luc, Brussels, Belgium talks to us about the progress being made in the treatment of head and neck cancer, such as immunotherapy involving anti-PD-1 antibodies, giving us details of some of the considerations that must be considered. Specialists are also keen to understand how knowledge of a patient’s genetic mutations could help assign the most appropriate treatment, and Dr Machiels explains how they are attempting to answer this question. This interview was recorded at the 2017 European Society for Medical Oncology (ESMO) conference held in Madrid, Spain.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter